Yanqiao Zhang

23PUBLICATIONS
117CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersAllergyMolecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jul 16, 2026
Elevated CHAF1A suppresses type I interferon production and causes immunotherapy resistance in esophageal squamous cell carcinoma.

|Oct 30, 2025
A Robust Immunohistochemistry-Based Classification for BRAF V600E-Mutant Colorectal Cancer With Clinical Implications.

Chao Liu, Yuli Ruan, Tong Wu

|Oct 13, 2025
IL-17A blockade alleviates immune checkpoint inhibitor-associated psoriasiform rash: preclinical and clinical responses.

Yuli Ruan, Mengde Shi, Yue Ma

|May 16, 2025
Porustobart (HBM4003) plus Toripalimab as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma: A Multicenter, Open-Label, Phase I Study.

Ningning Zhang, Tian Liu, Ming Luo

|May 05, 2025
USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment.

Shuling Han, Luying Cui, Bojun Wang

|Mar 26, 2025
Current status of multiple markers in precision immunotherapy for colorectal cancer.

Chao Liu, Ya Lan, Hong Wang

Pageof 4

Frequent Collaborators

6 joint publications

Chao Liu

4 joint publications

Bojun Wang

3 joint publications

Luying Cui

3 joint publications

Yuanyu Liao